Outset Medical, Inc.
OM
$14.20
$0.533.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.72% | 5.62% | -3.41% | -5.59% | -24.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.72% | 5.62% | -3.41% | -5.59% | -24.01% |
| Cost of Revenue | 11.05% | -4.88% | -19.96% | -18.78% | -37.87% |
| Gross Profit | 21.31% | 29.84% | 44.45% | 37.21% | 26.99% |
| SG&A Expenses | -23.92% | -29.05% | -29.22% | -30.15% | -15.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.97% | -25.70% | -29.94% | -30.75% | -26.87% |
| Operating Income | 45.18% | 51.68% | 53.17% | 47.55% | 29.24% |
| Income Before Tax | 46.25% | 35.48% | 33.38% | 39.78% | 21.88% |
| Income Tax Expenses | -31.13% | -29.01% | -103.57% | 111.63% | 13.53% |
| Earnings from Continuing Operations | 46.19% | 35.45% | 33.58% | 39.50% | 21.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.19% | 35.45% | 33.58% | 39.50% | 21.78% |
| EBIT | 45.18% | 51.68% | 53.17% | 47.55% | 29.24% |
| EBITDA | 46.37% | 53.49% | 55.36% | 48.97% | 30.19% |
| EPS Basic | 89.51% | 68.88% | 36.71% | 40.20% | 26.18% |
| Normalized Basic EPS | 89.53% | 76.45% | 46.77% | 40.48% | 26.28% |
| EPS Diluted | 89.51% | 68.88% | 36.71% | 40.20% | 26.18% |
| Normalized Diluted EPS | 89.53% | 76.45% | 46.77% | 40.48% | 26.28% |
| Average Basic Shares Outstanding | 413.10% | 107.43% | 4.95% | 1.18% | 5.96% |
| Average Diluted Shares Outstanding | 413.10% | 107.43% | 4.95% | 1.18% | 5.96% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |